Week of September 6, 2009
Gail Humble, MD
Dr. Humble serves as Medical Director for Blue Pacific Aesthetic Medical Group in El Segundo. She served as co-investigator in the first and second protocol of the Blue Pacific Medical Group Study on Sculptra. The safety data from this study was used in submission to the FDA that led to the approval of Scluptra in 2004. Dr. Humble also serves as a consultant, speaker, and national trainer for Sanofi- Aventis Pharmaceuticals. She is also a trainer and consultant for Bioform Medical.
At the upcoming Anti-Aging Conference: Clinical Applications for In-Office Procedures in San Jose, California (September 9-12, 2009), Dr. Humble will present, Facial Sculpting with Poly-L-Lactic Acid, a session in the workshop, AESTHETIC MEDICINE, on Friday, September 11th. With aging, the combined effects of photo injury, fat atrophy, and changes in facial muscle balance cause both wrinkles and contour defects. The best approach to lower facial enhancement involves restoring volume loss. Poly-L-lactic acid is a volumetric filler used for facial sculpting. The properties, risks, indications, and contraindications of poly-L-lactic acid will be reviewed, as well as the clinical trials leading to the substance’s FDA approval.
For more information call the A4M today; 1-888-997-0112.
